AIm: Most dural arteriovenous fistulas (DAVFs) can be treated safely and effectively with endovascular Onyx embolization. Balloon-assisted endovascular Onyx embolization of intracranial DAVFs is especially suitable for arterial protection and arterial flow reduction in complicated DAVFs. We systemically report our experience in the use of arterial balloon for Onyx embolization of DAVF and evaluate the clinical outcomes. mATERIAL and mETHods: Clinical records of 12 consecutive DAVFs patients (five women, seven men) treated with arterial balloon-assisted endovascular Onyx embolization were retrospectively collected to analysis their presenting symptoms, angiographic features, endovascular treatments, and clinical outcomes. yÖNTEm ve GEREÇLER: Arteriyel balon yardımlı endovasküler Onyx embolizasyonuyla tedavi edilen 12 DAVF hastasının (beş kadın, yedi erkek) klinik kayıtları, geliş belirtileri, anjiyografik özellikleri, endovasküler tedavileri ve klinik sonuçları analiz edilmek üzere retrospektif olarak toplandı.
INTRODUCTION
The balloon-assisted technique was incipiently used in the embolization of wide-neck aneurysm with coils or Onyx. The balloon helped to shape the coil or control the migration of Onyx during embolization. Balloons were also used to block blood supply and detachable balloons were used in the treatment of carotid cavernous sinus fistula. The balloonassisted technique in DAVF embolization was reported in some cases to control Onyx migration. But the use of balloon aiming to protect intracranial arteries in DAVF was not reported so far. We systemically describe the use of arterial balloon in the embolization of 12 consecutive intracranial DAVFs patients and evaluate the benefits.
MATERIAL and METHODS
Patients with intracranial DAVFs treated with Onyx embolization between August 2007 and August 2012 were retrospectively reviewed. During this period, 12 patients were treated with Onyx embolization adjunct to arterial balloonassisted technique. There were 5 women and 7 men with ages ranging from 18 to 66 (mean age 43 years). One patient presented with the symptom of intracranial hemorrhage, 6 with progressive headaches, 3 with tinnitus, and 4 with chemosis. One patient in this series has been reported previously (7) ( Table I) .
Angiographic Analysis
Based on the presence of cortical or retrograde venous sinus drainage, 7 DAVFs were classified as Cognard IIa, 1 lesions as III, 3 lesions as IV and 1 lesions as V. The arterial supplies were the middle meningeal artery (MMA), meningeal hypophyseal artery (MHA) and posterior meningeal artery (PMA). Of the 12 DAVFs, 1 DAVF located at the transverse and sigmoid sinus (TS-SS), 7 located at the cavernous sinus (CS) and 4 located at the tentorium.
Endovascular Procedure
Nine patients underwent transarterial onyx embolization and 3 patients underwent transvenous onyx embolization. All the patients were placed under general anesthesia and transfemoral arteriography was performed. Systemic heparinization was achieved during the procedures with heparin 5,000 U bolus followed by 1,000 U of heparin every hour.
TECHNIqUE

Transarterial
After a guiding catheter was placed into the feeding artery via a transfemoral approach, feeders of DAVF were selectively catheterized with a microcatheter (Marathon; MTI-EV3, Irvine, CA, USA) over microwire (Mirage, MTI-EV3, Irvine, CA, USA). For lesion cures, Onyx-18 was used as the embolic agent in attempt to "push" the Onyx across the arteriovenous shunts and into the proximal draining vein.
In 11 patients, the balloon was placed in the ICA or VA during the injection of Onyx-18. During injection of Onyx, the balloon was temporarily inflated to prevent migration of onyx into intracranial arteries. The balloon was deflated during the long interval of onyx injection and the one continuous balloon inflation was less than five minutes.
In 1 patient, the balloon catheter was positioned in the feeding artery proximal to the tip of microcatheter. During injection of Onyx, the balloon was temporarily inflated to increase proximal resistance, aid plug formation in fistulas and control distal Onyx migration, resulting in better control of reflux and enhanced distal penetration.
Transvenous
In three cases we used the transvenous embolization. Patient outcomes were clinically graded at follow-up evaluation after discharge from the hospital. Clinical outcome was graded according to the modified Rankin score (mRS) (4).
RESULTS
A total of 9 transarterial and 3 transvenous Onyx injection were performed adjunct to arterial balloon-assisted technique. Five transarterial Onyx embolizations were performed via MMA, 2 via MHA, 1 via MHA &MMA and 1 via PMA. Three transvenous embolizations were performed via IPS to CS (Table I ).
There were 10 sessions of balloon inflation in the ICA and 1 in the vertebral artery to provide protection. Another 1 session of balloon inflation was in the MMA to decrease the blood flow. Immediately following embolization, there was complete occlusion in 11 patients and partial occlusion in 1. The fistula was incompletely occluded because of early termination due to distal Onyx migration. This patient had a complex arterial supply and further treatment (endovascular or surgical) would be according to following angiography and clinical symptom. (Table II) .
ILLUSTRATIVE CASES
Patient 1 (arterial protection in TA embolization)
This 29-year-old man developed a headache and dizzy for about 10 years. Cerebral angiography revealed a DAVF involving the right tentorium ( Figure 1A ). The artery supply was from the MHA. We navigated a microcatheter into MHA of right ICA to get a position optimal for Onyx injection. A HyperGlide balloon (4*20, MTI-EV3, Irvine, CA, USA) was advanced into the MHA segment of ICA for protection (Figure  1 B) . Transarterial balloon occlusion produced good protection of intracranial feeding artery. Angiography after transarterial Onyx-18 embolization showed complete obliteration of the lesion ( Figure 1C ). The patient's symptoms were completely resolved after the procedure. 
Patient 2 (arterial flow reduction in TA embolization)
This 45-year-old woman presented with tinnitus for 3 months. Cerebral angiography revealed a DAVF involving the right TS-SS (Figure 2A ). The artery supply was from the posterior branch and petrosquamosal branch of right MMA, right occipital artery (OA) and right posterior auricular artery (PAA). We navigated a microcatheter into posterior branch of right MMA to get a position optimal for Onyx injection. A HyperGlide balloon (4*20, MTI-EV3, Irvine, CA, USA) was advanced into the MMA to control the migration of onyx ( Figure 2B ). Transarterial balloon occlusion produced good control of blood supply from MMA and provided a more effective penetration. Angiography after transvenous embolization Onyx-18 showed partial obliteration of the lesion. The residual lesion was supplied by the petrosquamosal branch of right MMA, right OA and right PAA ( Figure 2C ). The tinnitus symptoms were completely resolved after the procedure.
Patient 3 (arterial protection in TV approach)
This 38-year-old woman presented with right eye chemosis. Cerebral angiography revealed a DAVF involving the right CS ( Figure 3A) . Transvenous approach was used through IPS to Angiography showed complete occlusion of the DAVF ( Figure  3C ). The patient's symptoms improved after the procedure and were completely resolved at follow-up.
DISCUSSION
The aggressive type of intracranial DAVF with either direct or indirect retrograde filling of a leptomeningeal vein has a high propensity of ischemia, intracranial hypertension, and cerebral bleeding (17) . If left untreated, the mortality rate is 10.4%, the annual bleeding and the non-hemorrhagic neurological deficit risks are 8.1% and 6.9%, respectively. Therefore, consensus exists, that aggressive-type DAVFs should be treated (2, 5, 9, 18) .
Onyx-based embolization is a promising technique option as a definitive treatment for DAVFs (3, (10) (11) (12) . For DAVFs with high flow, easy reflux or anastomosis with intracranial vessels, it would not be an easy deal to make a better control of Onyx penetration into the fistula. Improper flow or reflux of Onyx may cause unfavorable embolization or even serious complications leaving unexpected prognosis (14) .
Balloon-assisted technique was proposed for the endovascular treatment of broad-based aneurysms since the late 1990s. Balloon-assisted transarterial Onyx embolization of craniofacial vascular malformations or DAVFs has been described in other small series (1, 13). Rezende et al. (13) reported the usage of a temporary balloon in the ophthalmic segment of the ICA during transarterial Onyx embolization via the MMA to treat a sphenoparietal DAVF. This technique prevented the untoward passage of Onyx into the ICA via the recurrent meningeal branch of the OA, and complete occlusion Some case reports first point out the balloon-assisted technique in embolization of DAVF can promote distal onyx migration. We use the balloon-assisted embolization in the feeding trunk of MMA to decrease the blood flow within the feeding artery in one DAVF patient. The balloon produced better control of the material's reflux and more distal penetration into the fistula by simulating a "wedged" effect. Decreasing the rapid flow of feeding artery could minimize the risk of distal migration of the embolic material into the systemic venous or pulmonary circulation caused by highflow shunting. Some rare complications were reported of Onyx migration causing symptomatic pulmonary complications of transarterial acrylic embolization of brain arteriovenous malformations (8) .
The use of balloon may increase the incidence of ischemic affairs (15) . But in our group, no balloon related complication
occurred. The inflation duration of balloon should not exceed five minutes and intermittent deflation is recommended if the onyx injection duration lasts long.
In nine DAVFs cases related to CS, the feeding arteries were from both ECA and ICA. During transarterial Onyx injection through MMA or MHA, balloon was inflated in the feeding MHA opening to protect ICA. During Onyx injection transvenous through IPS, balloon was inflated in the feeding MHA opening not only to protect ICA but also decrease the flow rate in the CS. We inflated the balloon in the ICA at the site of the meningeal feeding arteries, which have anastomotic connections with the target vessel being embolized. The balloon could prevent Onyx from occluding the intracranial artery and/or causing distal embolism via those anastomotic channels. One tentorium DAVF patient with feeding artery of OA and PMA was embolized by inflated balloon in vertebral artery to provide protection of intracranial artery.
Complications occurred in the previously treated patients where a balloon was not used to protect intracranial feeding arteries or anastomotic arteries. In some previous patients, the MHA was blocked during onyx injection because of reflux or embolized through anastomotic connections. The balloon assisted embolization also presented a better total embolization rate. That might because of less reflux into feeding artery or influx into anastomotic arteries which provided a better control of onyx and a longer injection time for the elimination of the fistula.
It should be noted, however, no clear consensus exists on the best embolization strategy in complicated cases. We used the balloon-assisted embolization in one case to produced better control of the Onyx reflux and made more distal penetration into the fistula. For another 11 cases, our clinical experience hold the idea that when the DAVFs located in the tentorium or CS and supplied by both ECA and ICA, balloon is better used to protect the intracranial anastomosis artery. But some cases with no feeding MHA showed recurrent of Onyx into MHA and lead to clinical symptoms. This novel technique cannot substitute for proper use of the reflux-hold-reinjection technique.
CONCLUSIONS
Balloon adjunct to Onyx embolization can provide protection of intracranial artery in the treatment of intracranial DAVFs as a complementary method.
